Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), will introduce three new oncology biosimilars, further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback